These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 30244417)

  • 1. ASO Author Reflections: Elimination of Breast Cancer Surgery in Complete Responders After Neoadjuvant Chemotherapy: Imaging Perspective.
    Rauch GM
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):628-629. PubMed ID: 30244417
    [No Abstract]   [Full Text] [Related]  

  • 2. ASO Author Reflections: The Role of Imaging Modalities in Omitting Surgery in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.
    Palshof FK; Kroman N; Tvedskov TF
    Ann Surg Oncol; 2021 Nov; 28(12):7430-7431. PubMed ID: 34023947
    [No Abstract]   [Full Text] [Related]  

  • 3. ASO Author Reflections: Role of Genomic Assay to Predict Neoadjuvant Chemotherapy Response in Breast Cancer.
    Pease AM; James TA
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):573-574. PubMed ID: 30783852
    [No Abstract]   [Full Text] [Related]  

  • 4. ASO Author Reflections: Moving Forward De-escalation of Axillary Surgery After Neoadjuvant Treatment in Breast Cancer.
    Rubio IT
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):638-639. PubMed ID: 30284130
    [No Abstract]   [Full Text] [Related]  

  • 5. ASO Author Reflections: How Can We Eliminate Breast Surgery in Patients Who Achieved Clinical Complete Response After Neoadjuvant Chemotherapy?
    Sawaki M; Kataoka A
    Ann Surg Oncol; 2023 Jun; 30(6):3233-3234. PubMed ID: 36765007
    [No Abstract]   [Full Text] [Related]  

  • 6. ASO Author Reflections: Neoadjuvant Chemotherapy Does Not Affect Short-Term Outcomes After Breast Cancer Surgery.
    Konishi T; Fujiogi M; Tanabe M; Seto Y; Yasunaga H
    Ann Surg Oncol; 2022 May; 29(5):3011-3012. PubMed ID: 34997419
    [No Abstract]   [Full Text] [Related]  

  • 7. ASO Author Reflections: Improving Patient Selection for Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy.
    Kantor O; James TA
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):640-641. PubMed ID: 30302645
    [No Abstract]   [Full Text] [Related]  

  • 8. ASO Author Reflections: Role of Contrast-Enhanced Spectral Mammography in the Assessment of Residual Breast Cancer After Neoadjuvant Systemic Therapy.
    Hilal T; Patel BK
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):652-653. PubMed ID: 30324476
    [No Abstract]   [Full Text] [Related]  

  • 9. ASO Author Reflections: Selecting Patients for Elimination of Surgery Trials-Predicting Residual Invasive and In Situ Disease in Patients with HER2-Positive Breast Cancer After Neoadjuvant Systemic Therapy.
    Sun SX; Kuerer HM
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):804-805. PubMed ID: 31654165
    [No Abstract]   [Full Text] [Related]  

  • 10. ASO Author Reflections: Transoral Robotic Surgery Combined with Neoadjuvant Chemotherapy for Management of Advanced Laryngohypopharyngeal Cancer.
    Park YM; Kim SH
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):894-895. PubMed ID: 30288650
    [No Abstract]   [Full Text] [Related]  

  • 11. ASO Author Reflections: Disparities in Outcome and Surgical Management Following Neoadjuvant Chemotherapy for Breast Cancer.
    Relation T; Oppong BA
    Ann Surg Oncol; 2021 Oct; 28(11):6498-6499. PubMed ID: 33660126
    [No Abstract]   [Full Text] [Related]  

  • 12. ASO Author Reflections: Postmastectomy Radiotherapy for Breast Cancer Patients After Neoadjuvant Chemotherapy, by Molecular Subtype.
    Ma JC; Zhong XR; Luo T; Liu L
    Ann Surg Oncol; 2021 Sep; 28(9):5096-5097. PubMed ID: 33604825
    [No Abstract]   [Full Text] [Related]  

  • 13. ASO Author Reflections: Identifying pCR After Neoadjuvant Chemotherapy: The Key to Treatment De-escalation in Breast Cancer.
    Lim DW; Hong NJL
    Ann Surg Oncol; 2022 Dec; 29(Suppl 3):570-571. PubMed ID: 34435298
    [No Abstract]   [Full Text] [Related]  

  • 14. ASO Author Reflections: Avoiding Mastectomy: The Benefit of Neoadjuvant Chemotherapy for Large Unifocal Breast Tumors.
    Petruolo O; Barrio AV
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):755-756. PubMed ID: 32444911
    [No Abstract]   [Full Text] [Related]  

  • 15. ASO Author Reflections: Use of Axillary Staging Surgery Before Systemic Therapy in Breast Cancer Highlights a Need for Implementation Science in Surgery.
    Iles K; Downs-Canner S
    Ann Surg Oncol; 2022 Dec; 29(Suppl 3):575-576. PubMed ID: 34599433
    [No Abstract]   [Full Text] [Related]  

  • 16. ASO Author Reflections: Prognostic Role of Pathologic Complete Response After Neoadjuvant Therapy in Digestive Cancer.
    Wan T; Zhou YM
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):587. PubMed ID: 31011901
    [No Abstract]   [Full Text] [Related]  

  • 17. ASO Author Reflections: Ultrasound-Guided Restaging and Localization of Axillary Lymph Nodes After Neoadjuvant Chemotherapy.
    Kim WH; Kim HJ
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):644-645. PubMed ID: 30315382
    [No Abstract]   [Full Text] [Related]  

  • 18. ASO Author Reflections: Rate of Axillary Lymph Node Dissection has Decreased in Patients Treated with Neoadjuvant Systemic Therapy.
    Nguyen TT; Boughey JC
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):693-694. PubMed ID: 30421050
    [No Abstract]   [Full Text] [Related]  

  • 19. ASO Author Reflections: Changes in Use of Neoadjuvant Chemotherapy Over Time-Highest Rates of Use Now in Triple-Negative and HER2+ Disease.
    Murphy BL; Boughey JC
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):695-696. PubMed ID: 30465221
    [No Abstract]   [Full Text] [Related]  

  • 20. ASO Author Reflections: Is It Worth the Risk? The Benefit of Neoadjuvant Chemotherapy in Elderly Patients with Breast Cancer.
    Williams AD; Barrio AV
    Ann Surg Oncol; 2022 Dec; 29(13):8012-8013. PubMed ID: 35941345
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.